secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K/A
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0000950170-24-009973
Event type: other_material
Sentiment:  neutral
Materiality: 0.00
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus Pharmaceuticals files non-substantive 8-K/A to correct Exhibit 5.1 signature
--------------------------------------------------------------------------------

- Amendment corrects omitted conformed signature on Lowenstein Sandler LLP legal opinion filed as Exhibit 5.1.
- Original 8-K filed Feb 1, 2024 remains unchanged; no new financial or business disclosures.
- Underwriting agreement and two press releases from Jan 30-31, 2024 are incorporated by reference unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024009973/0000950170-24-009973-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024009973/crbp-20240130.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-009973

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer